PPP2R2B

protein phosphatase 2 regulatory subunit Bbeta, the group of WD repeat domain containing|Protein phosphatase 2 regulatory subunits

Basic information

Region (hg38): 5:146580742-147084784

Previous symbols: [ "SCA12" ]

Links

ENSG00000156475NCBI:5521OMIM:604325HGNC:9305Uniprot:Q00005AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spinocerebellar ataxia type 12 (Supportive), mode of inheritance: AD
  • spinocerebellar ataxia type 12 (Strong), mode of inheritance: AD
  • spinocerebellar ataxia type 12 (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spinocerebellar ataxia 12ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic10581021; 11719278; 14526180; 16138911; 20301381; 20629122
The condition involves expansion of triplet repeats

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PPP2R2B gene.

  • not_specified (30 variants)
  • not_provided (29 variants)
  • PPP2R2B-related_disorder (6 variants)
  • Spinocerebellar_ataxia_type_12 (5 variants)
  • Neurodevelopmental_disorder (1 variants)
  • Global_developmental_delay (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP2R2B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000181675.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
3
missense
49
clinvar
5
clinvar
54
nonsense
2
clinvar
2
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 0 0 52 8 0
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PPP2R2Bprotein_codingprotein_codingENST00000336640 9496412
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9850.0153125739081257470.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.251672710.6160.00001593004
Missense in Polyphen2884.7410.33042988
Synonymous0.447961020.9440.00000615812
Loss of Function3.90221.50.09300.00000119245

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005800.0000580
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00003540.0000352
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. Within the PP2A holoenzyme complex, isoform 2 is required to promote proapoptotic activity (By similarity). Isoform 2 regulates neuronal survival through the mitochondrial fission and fusion balance (By similarity). {ECO:0000250}.;
Disease
DISEASE: Spinocerebellar ataxia 12 (SCA12) [MIM:604326]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA12 is an autosomal dominant cerebellar ataxia (ADCA). {ECO:0000269|PubMed:10581021}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Dopaminergic synapse - Homo sapiens (human);Tight junction - Homo sapiens (human);mRNA surveillance pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Chagas disease (American trypanosomiasis) - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Wnt Signaling Pathway and Pluripotency;PI3K-Akt Signaling Pathway;Glycogen Metabolism;GPCR Dopamine D1like receptor;insulin Mam;PDGFR-beta signaling pathway;ATR signaling pathway;insulin (Consensus)

Recessive Scores

pRec
0.246

Intolerance Scores

loftool
0.720
rvis_EVS
-0.74
rvis_percentile_EVS
13.94

Haploinsufficiency Scores

pHI
0.928
hipred
Y
hipred_score
0.825
ghis
0.670

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.866

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ppp2r2b
Phenotype
hematopoietic system phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
mitotic cell cycle;apoptotic process;regulation of phosphoprotein phosphatase activity;peptidyl-serine dephosphorylation
Cellular component
protein phosphatase type 2A complex;mitochondrion;mitochondrial outer membrane;cytosol;cytoskeleton
Molecular function
protein serine/threonine phosphatase activity;protein binding;protein phosphatase regulator activity